BioSpace News Archive

Precision BioSciences, Inc. today announced financial results for the first quarter ended March 31, 2022 and provided a business update.

Bio-Thera Solutions, Ltd. today announced that dosing has begun in a Phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of BAT7104, a bispecific antibody that specifically blocks the interaction of human PD-L1 and CD47 with their corresponding receptors.

Moderna, Inc. today announced that it will host its in-person Science and Technology Day for analysts and investors at 9:00 a.m. ET on Tuesday, May 17 in Boston, MA.

NeoGenomics, Inc. announced the appointment of Vishal Sikri as President and Chief Commercial Officer of Inivata and the departure of former President of Inivata Dr. Clive Morris.

Surface Oncology reported financial results and corporate highlights for the first quarter of 2022 as well as upcoming anticipated corporate milestones.

Resverlogix Corp. today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s request for a Type C meeting to review the clinical trial protocol for its Phase 3 study of apabetalone in high-risk COVID-19 outpatients.

Biomind Labs Inc. is pleased to announce that its CEO Alejandro Antalich will be debating in the “PSYCH Symposium: London 2022.

Genenta Science announces the appointment of Tim Obara, a highly experienced commercial healthcare executive, as Vice President Business Development.

Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, reported financial results for the first quarter ended March 31, 2022 and provided a business update.

Verrica Pharmaceuticals Inc. today announced financial results for the first quarter ended March 31, 2022.